Histamine inhibits the production of interleukin-12 through interaction with H2 receptors

Journal of Clinical Investigation

Volumn 102, Issue 10, 1998, Pages 1866-1873

  Van Der Pouw Kraan, Tineke C T M ^a,d   Snijders, Alies ^b   Boeije, Leonie C M ^a   De Groot, Els R ^a   Alewijnse, Astrid E ^c   Leurs, Rob ^c   Aarden, Lucien A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

Allergy and immunology; Cytokines; Interferon gamma; Monocytes; Th1 cells

Indexed keywords

CYCLIC AMP; GAMMA INTERFERON; HISTAMINE; HISTAMINE H2 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12;

ARTICLE; ATOPY; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; NORMAL HUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0032533556     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3692     Document Type: Article

References (67)

1. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
2. + T lymphocytes in atopic patients. J. Immunol. 144:4651-4656.
3. Punnonen, J., G. Aversa, B.G. Cocks, A.N.J. McKenzie, S. Menon, G. Zurawski, R. De Waal Malefijt, and J.E. De Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:3730-3734.
4. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, Human Immunodeficiency Virus-seropositive individuals. J. Clin. Invest. 91:759-765.
5. Kapsenberg, M.L., H.M. Jansen, J.D. Bos, and E.A. Wierenga. 1992. Role of type 1 and type 2 T helper cells in allergic disease. Curr. Opin. Immunol. 4:788-793.
6. Meyaard, L., S.A. Otto, I.P.M. Keet, R.A.W. Van Lier, and F. Miedema. 1994. Changes in cytokine secretion patterns of CD4+ T cell clones in HIV infection. Blood. 84:4262-4268.
7. O'Garra, A., and K. Murphy. 1993. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5:880-886.
8. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:547-549.
9. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:4008-4027.
10. Gately, M.K., B.B. Desai, A.G. Wolitzki, P.M. Quinn, C.M. Dwyer, F.J. Podlaski, P.C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A.S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874-882.
11. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, K. Kelleher, S.H. Herrmann, S.C. Clark, L. Azzoni, S.H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074-3081.
12. Scharton-Kersten, T., L.C.C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmaniasis. J. Immunol. 154: 5320-5330.
13. Hayes, M.P., J. Wang, and M.A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-τ of lipopolysaccharide-inducible p35 and p40 genes. Blood. 86:646-650.
14. Snijders, A., C.M.U. Hilkens, T.C.T.M. van der Pouw Kraan, M. Engel, L.A. Aarden, and M.L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207-1212.
15. Ma, X., J.M. Chow, G. Gri, G. Carra, F. Gerosa, S.F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon τ in monocytic cells. J Exp. Med. 183:147-157.
16. D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J Exp. Med. 178:1041-1048.
17. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181:537-546.
18. Marth, T., and B.L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987-1995.
19. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:228-231.
20. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775-779.
21. Panina-Bordignon, P., D. Mazzeo, P. Di Lucia, D. D'Ambrosio, R. Lang, L. Fabbri, C. Self, and F. Sinigaglia. 1997. β2-agonists prevent Th1 development by selective inhibition of IL-12. J. Clin. Invest. 100:1513-1519.
22. Leurs, R., M.J. Smit, and H. Timmerman. 1995. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:413-463.
23. Hill, S.J. 1990. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:45-83.
24. Smit, M.J., R. Leurs, S.R. Shukrula, A. Bast, and H. Timmerman. 1994. Rapid desensitisation of the histamine H2 receptor on the human monocytic cell line U937. Eur. J. Pharmacol. 288:17-25.
25. Cameron, W., K. Doyle, and R.E. Rocklin. 1986. Histamine type 1 (H1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J. Immunol. 136:2116-2120.
26. Beer, D.J., S.M. Matloff, and R.E. Rocklin. 1984. The influence of histamine on immune and inflammatory responses. Adv. Immunol. 35:209-268.
27. Dohlsten, M., H.O. Sjögren, and R. Carlsson. 1987. Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-τ production. Cell. Immunol. 109:65-74.
28. Vannier, E., L.C. Miller, and C.A. Dinarello. 1991. Histamine suppresses gene expression and synthesis of tumor necrosis factor α via histamine H2 receptors. J. Exp. Med. 174:281-284.
29. Dohlsten, M., T. Kalland, H.O. Sjögren, and R. Carlsson. 1988. Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand. J Immunol. 27:527-532.
30. Raible, D.G., E.S. Schulman, J. Dimuzio, R. Cardillo, and T.J. Post. 1992. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J. Immunol. 148:3536-3542.
31. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S.F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
32. Schindler, R., and C.A. Dinarello. 1989. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J. Immunol. Methods. 116:159-165.
33. Helle, M., L. Boeije, E.R. De Groot, A. De Vos, and L.A. Aarden. 1991. Sensitive ELISA for interleukin 6. Detection of IL-6 in biological fluids: synovial fluids and sera. J. Immunol. Methods. 138:47.
34. Aarden, L.A., E.R. De Groot, O.L. Schaap, and P.M. Lansdorp. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17:1411-1416.
35. Bouaboula, M., P. Legoux, B. Pess'gu, B. Delpech, X. Dumont, M. Piechaczyk, P. Casellas, and D. Shire. 1992. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267:21830-21838.
36. 2. Ann. N.Y. Acad. Sci. 795:147-157.
37. van der Pouw Kraan, T.C.T.M., L.C.M. Boeije, E.R. De Groot, S.O. Stapel, A. Snijders, M.L. Kapsenberg, J.S. van der Zee, and L.A. Aarden. 1997. Reduced production of interleukin 12 (IL-12) and IL-12-dependent IFN-gamma release by allergic asthma patients. J. Immunol. 158:5560-5565.
38. Ma, X., A. D'Andrea, M. Kubin, M. Aste-Amezaga, A. Sartori, J. Monteiro, L. Showe, M. Wysocka, and G. Trinchieri. 1995. Production of interleukin-12. Res. Immunol. 146:432-438.
39. Coffey, R.G., V.A. Alberts, and L.L. Weakland. 1990. Prostaglandin-dependent desensitization of human monocyte cAMP responses. J. Leukocyte Biol. 48:557-564.
40. Bodor, J., A. Spetz, J.L. Strominger, and J.F. Habener. 1996. cAMP inducibility of transcriptional repressor ICER in developing and mature T lymphocytes. Proc. Natl. Acad. Sci. USA. 93:3536-3541.
41. Haraguchi, S., R.A. Good, and N.K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today. 16:595-603.
42. Murphy, T.L., M.G. Cleveland, P. Kulesza, J. Magram, and K.M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:5258-5267.
43. Jacob, T., B.N. Huspith, Y.E. Latchman, R. Rycroft, and J. Brostoff. 1990. Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin. Exp. Immunol. 79:380-384.
44. Leung, D.Y.M., L. Key, J.J. Steinberg, M.C. Young, M. Von Deck, R. Wilkinson, and R.S. Geha. 1988. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol. 140:84-88.
45. Trask, D.M., S.C. Chan, S.E. Sherman, and J.M. Hanifin. 1988. Altered leukocyte protein kinase activity in atopic dermatitis. J. Invest. Dermatol. 90: 526-531.
46. Foley, P., F. Kazazi, R. Biti, T.C. Sorrell, and A.L. Cunningham. 1992. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology. 75:391-397.
47. 2 production by macrophages infected with HIV. Cell. Immunol. 152:120-130.
48. Chehimi, J., S.E. Starr, I. Frank, A. D'Andrea, X. Ma, R.R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
49. 2 production. Blood. 89:570-576.
50. Marshall, J.D., S.E. Robertson, G. Trinchieri, and J. Chehimi. 1997. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J. Immunol. 159:5705-5714.
51. Delemarre, F.G.A., A. Stevenhagen, F.P. Kroon, M.Y. van Eer, P.L. Meenhorst, and R. van Furth. 1995. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS. 9:441-445.
52. Hofmann, B., P. Nishanian, T. Nguyen, M. Liu, and J.L. Fahey. 1993. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 7:659-664.
53. Brockmeyer, N.H., E. Kreuzfelder, L. Mertins, N. Chalabi, W. Kirch, N. Scheiermann, M. Goos, and E.E. Ohnhaus. 1988. Immunomodulatory properties of cimetidine in ARC patients. Clin. Immunol. Immunopathol. 48:50-60.
54. Tasaka, K., K. Kurokawa, Y. Nakayama, and M. Kakimoto. 1986. Effect of histamine on delayed-type hypersensitivity in mice. Immunopharmacology. 12:69-77.
55. Ptak, W., G.P. Geba, and P.W. Askenase. 1991. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J. Immunol. 146:3929-3936.
56. Testa, B., F. Mazzel, M. Mesolella, A. Maione, D. Testa, and C. Mesolella. 1989. Histamine 2 antagonists in allergic rhinitis. Relationship of clinical response and serum concentrations of total and specific IgE antibody levels. Arch. Otolaryngol. Head Neck Surg. 115:950-953.
57. Yang, P.C., T. Liu, T.Y. Zhang, and D.S. Fan. 1997. The effect of the H2 antagonist cimetidine on the numbers of CD4+ and CD8+ cells in the nasal mucosa of patients with allergic rhinitis. Clin. Otolaryngol. 22:93-95.
58. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380-5384.
59. Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1994. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180:2365-2370.
60. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321-5329.
61. Van der Pouw Kraan, T., C. Van Kooten, H.J.A.M. Rensink, and L.A. Aarden. 1992. IL-4 production by human T cells. Differential regulation of IL-4 versus IL-2 production. Eur. J. Immunol. 22:1237-1241.
62. Naclerio, R.M., D. Proud, A.G. Togias, N.F. Adkinson, D.A. Meyers, A. Kagey-Sobotka, M. Plaut, P.S. Norman, and L.M. Lichtenstein. 1985. Inflammatory mediators in late antigen-induced rhinitis. N. Engl. J. Med. 313:65-70.
63. Deyer, J., K. Warren, S. Merlin, D.D. Metcalfe, and M. Kaliner. 1982. Measurement of plasma histamine: description of an improved method and normal values. J. Allergy Clin. Immunol. 70:82-87.
64. Kimata, H., M. Fujimoto, C. Ishioka, and A. Yoshida. 1996. Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody. J. Exp. Med. 184:357-364.
65. Casolaro, V., G. Spadara, and G. Marone. 1990. Human basophil releasability VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am. Rev. Respir. Dis. 142:1108-1111.
66. Gaddy, J.N., and W.W. Busse. 1986. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am. Rev. Respir. Dis. 134: 969-974.
67. Marone, G., R. Giugliano, G. Lembo, and F. Ayala. 1986. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J. Invest. Dermatol. 87:19-23.